Home
True Diagnostics

True Diagnostics Market Share Analysis for June 2026

Industry: N/A

Domaintruediag.com

Year Founded2011

Employees51 - 200

Annual Revenue$50M - $75M

True Diagnostics

True Diagnostics (including company regionals)

truediag.com

See more website traffic and engagement information

True Diagnostics Revenue up to June 2026 is 50M - 75M

revenue generated by True Diagnostics top domains

True Diagnostics top domains revenue over 3 years

Revenue for True Diagnostics top domains

truediag.com50M - 75M

See more with Sales Intelligence

Total visits to True Diagnostics's top domains

Understand True Diagnostics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

truediag.com2.7K

See more with Sales Intelligence

Avg. visit duration in True Diagnostics's top domains

Analyze True Diagnostics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

truediag.com--

See more with Sales Intelligence

Avg. pageviews on True Diagnostics's top domains

See how True Diagnostics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

truediag.com1.20

See more with Sales Intelligence

True Diagnostics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by True Diagnostics

These are the website technologies, by industry, used by True Diagnostics top domains

Widget (3)

Twemoji

Content Management System (2)

WordPress

Email Services (2)

GoDaddy Email

Mobile (2)

Meta Viewport

More Technologies

3

See all

News & Signals from True Diagnostics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsTrue Diagnostics, Inc. is developing rapid, point-of-care immunoassay for SARS-CoV-2 on Apr 23rd '20.True Diagnostics has partnered with Veravas and Infectolab Americas to develop and commercialize a rapid, point-of-care immunoassay for SARS-CoV-2, the companies said on Thursday.

NewsTrue Diagnostics, Inc. partnered with Veravas, Inc. on Apr 16th '20.Point-of-care test developer True Diagnostics said today that it has entered into a strategic alliance with Veravas to commercialize VeraTest Biotin, a portable test that rapidly screens patient samples to determine whether biotin levels are present that could throw off the accuracy of diagnostic tests.